These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7575512)

  • 1. Carbamylation inhibits the ferroxidase activity of caeruloplasmin.
    Roxborough HE; Millar CA; McEneny J; Young IS
    Biochem Biophys Res Commun; 1995 Sep; 214(3):1073-8. PubMed ID: 7575512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma ascorbate levels and inhibition of the antioxidant activity of caeruloplasmin.
    Gutteridge JM
    Clin Sci (Lond); 1991 Sep; 81(3):413-7. PubMed ID: 1717196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ferroxidase activity of caeruloplasmin is reduced in haemodialysis patients.
    Roxborough HE; Mercer C; McMaster D; Maxwell AP; Young IS
    Nephron; 2000 Mar; 84(3):211-7. PubMed ID: 10720890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin C at concentrations observed in premature babies inhibits the ferroxidase activity of caeruloplasmin.
    Powers HJ; Loban A; Silvers K; Gibson AT
    Free Radic Res; 1995 Jan; 22(1):57-65. PubMed ID: 7889148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired biological activity of erythropoietin by cyanate carbamylation.
    Mun KC; Golper TA
    Blood Purif; 2000; 18(1):13-7. PubMed ID: 10686438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamylation of proteins and atherogenesis in renal failure.
    Roxborough HE; Young IS
    Med Hypotheses; 1995 Aug; 45(2):125-8. PubMed ID: 8531833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on ascorbate inhibition of ceruloplasmin ferroxidase activity.
    Løvstad RA
    Biometals; 1997 Apr; 10(2):123-6. PubMed ID: 9210294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroxidase and ascorbate oxidase activities of caeruloplasmin in synovial fluid from rheumatoid patients.
    Blake DR; Blann A; Bacon PA; Farr M; Gutteridge JM; Halliwell B
    Clin Sci (Lond); 1983 May; 64(5):551-3. PubMed ID: 6403279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyanate as a hemolytic factor.
    Mun KC; Kim HC; Kwak CS
    Ren Fail; 2000 Nov; 22(6):809-14. PubMed ID: 11104168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant properties of caeruloplasmin towards iron- and copper-dependent oxygen radical formation.
    Gutteridge JM
    FEBS Lett; 1983 Jun; 157(1):37-40. PubMed ID: 6862018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of fibrinogen carbamylation on fibrin clot formation and stability.
    Binder V; Bergum B; Jaisson S; Gillery P; Scavenius C; Spriet E; Nyhaug AK; Roberts HM; Chapple ILC; Hellvard A; Delaleu N; Mydel P
    Thromb Haemost; 2017 May; 117(5):899-910. PubMed ID: 28382370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma protein carbamylation and decreased acidic drug protein binding in uremia.
    Erill S; Calvo R; Carlos R
    Clin Pharmacol Ther; 1980 May; 27(5):612-8. PubMed ID: 7371359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caeruloplasmin: a plasma protein, enzyme, and antioxidant.
    Gutteridge JM
    Ann Clin Biochem; 1978 Nov; 15(6):293-6. PubMed ID: 736489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An automated method for the kinetic measurement of ferroxidase activity.
    Winkles J; Jones AF; Winyard P; Blake DR; Lunec J
    Ann Clin Biochem; 1988 May; 25 ( Pt 3)():250-4. PubMed ID: 3400981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of carbamylated haemoglobin in acute renal failure.
    Wynckel A; Randoux C; Millart H; Desroches C; Gillery P; Canivet E; Chanard J
    Nephrol Dial Transplant; 2000 Aug; 15(8):1183-8. PubMed ID: 10910442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material.
    Swain J; Gutteridge JM
    FEBS Lett; 1995 Jul; 368(3):513-5. PubMed ID: 7635210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome-dependent degradation of intracellular carbamylated proteins.
    Desmons A; Okwieka A; Doué M; Gorisse L; Vuiblet V; Pietrement C; Gillery P; Jaisson S
    Aging (Albany NY); 2019 Jun; 11(11):3624-3638. PubMed ID: 31170093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction formula for carbamylated haemoglobin in diabetic uraemic patients.
    Hammouda AM; Mady GE
    Ann Clin Biochem; 2001 Mar; 38(Pt 2):115-9. PubMed ID: 11269750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of inhibitor mixtures and the specific effects of different anions on the oxidase activity of caeruloplasmin.
    Curzon G; Speyer BE
    Biochem J; 1968 Aug; 109(1):25-34. PubMed ID: 5669845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary deficiency of ferroxidase (aka caeruloplasmin).
    Logan JI
    J Neurol Neurosurg Psychiatry; 1996 Nov; 61(5):431-2. PubMed ID: 8937333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.